Revere Partners

Revere Partners describes itself as the first independent venture capital fund focused exclusively on scaling innovative startups in the oral and dental health sector. Headquartered in New York, the firm operates in a category that is structurally underinvested relative to its size and patient impact. Founders building dental practice software, AI-enabled radiograph analysis, intraoral imaging, dental insurance technology, DSO operating tools, oral health monitoring devices, or tele-dentistry platforms fit the thesis. The category specialization gives the firm fluency in dental practice economics, payer mechanics, and the DSO consolidation trend that broader healthtech investors typically lack.

The fund invests at Seed and Series A with check sizes of $250k to $1M. It is based in the United States and concentrates on medical devices and MedTech alongside health IT and healthcare software. There is no stated AI focus.

Founders should approach with grounded understanding of dental practice operations, customer acquisition in a fragmented market of solo and group practices, and the role DSOs play as buyers and gatekeepers. Provider validation, a credible go-to-market that addresses cost-of-acquisition realities in dental SaaS, and clarity on reimbursement where relevant strengthen positioning. Limited public information is available about all named partners and the full portfolio, so outreach via dental industry events, DSO executives, and the firm’s website is typically how founders connect.